FluoroPharma, Inc.   Report issue

For profit Phase 2
Founded: Boston MA United States (2003)
Status: No NME R&D (2003)

Organization Overview

First Clinical Trial
2006
NCT00413647
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now